Yaohai Bio-Pharma, a leading Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in microbial expression systems, today announced the launch of its comprehensive microbial biologics platform. This integrated offering combines 15+ years of microbial expertise with expanded cGMP manufacturing capabilities, positioning the company as a strategic partner for global biopharmaceutical companies seeking to accelerate biologics development.
The platform addresses key industry challenges through three core pillars:
1. Advanced Microbial Expression Expertise
With over 15 years of specialized experience, Yaohai Bio-Pharma has developed deep expertise in microbial strain development, fermentation optimization, and downstream processing. The company’s team has successfully delivered 50+ projects across various expression systems, providing optimized processes for complex molecules including recombinant proteins, peptides, nucleic acids, and nanobodies.
2. End-to-End Development Services
Yaohai Bio-Pharma offers integrated services from gene synthesis to regulatory submission support. This comprehensive approach has demonstrated significant timeline reductions for clients navigating IND and NDA pathways with regulatory agencies including the FDA, EMA, and NMPA.
3. Scalable cGMP Manufacturing
The company’s advanced facilities include five fermentation lines with 7,500L total capacity, supported by quality control laboratories equipped with HPLC, CE, GC, and UV spectroscopy. Yaohai maintains excellent batch consistency (<5% variation) and delivery reliability (>98% on-time).
“Our enhanced capabilities address the growing industry need for reliable microbial biologics development partners,” said [Name], [Title] at Yaohai Bio-Pharma. “We are positioned to support projects from early development through commercial manufacturing, providing both technical excellence and regulatory expertise to accelerate drug development.”
The company offers flexible partnership models designed to meet the needs of organizations ranging from startups to established pharmaceutical companies.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a specialized microbial biologics CRDMO with a proven track record of over 200 successful CMC projects. The company’s platform spans the entire biologics development continuum, combining scientific expertise with operational excellence to advance innovative therapies.
